S-nitrosoglutathione (GSNO) is an endogenous S-nitrosylated glutathione derivative (GSH) involved in NO signaling. GSNO acts as a carrier of nitrosyl groups to cysteine (both free amino acid and its residues in proteins), a glutathionylation agent, and an NO donor. We investigated the effects of GSNO, GSH, and oxidized glutathione (GSSG) on the activity of two main ion pumps of the plasma membrane, Na+/K+-ATPase (NKA) and plasma membrane Ca2+-ATPase (PMCA). Plasma membranes were obtained from the rat cerebral cortex by differential centrifugation. Preincubation of the saponinpermeabilized plasma membranes at 37°C (but not at 0°C) with various concentrations of GSNO led to partial inhibition of ATPase activities of NKA and PMCA (on average, by 19.4 ± 2.2 and 42.1 ± 3% at 10 mM GSNO, respectively). The addition of GSH instead of GSNO did not affect the enzyme activities, while GSSG inhibited these enzymes much weaker than GSNO. The inhibited enzyme activities after the action of GSNO were partially restored after incubation of the membranes with a thiol-reducing agent, 2-mercaptoethanol. GSNO-dependent inhibition of NKA was not observed in the presence of ouabain (>1.0 μM), when only isozymes having an α1-subunit were active. GSNO inhibited both high- and lowsensitive to Ca2+ (calmodulin-dependent and calmodulin-independent) PMCA activities by 51 and 33%, respectively, with no changes in Km for Ca2+. It is assumed that GSNO or its degradation product(s), by modifying the thiol groups in NKA and PMCA molecules, partly inhibit their activity. Only NKA isozymes with α2 and α3 subunits, which are highly sensitive to ouabain, are likely to manifest such sensitivity. Inhibition of PMCA is not associated with a change in its sensitivity to Ca2+.
Similar content being viewed by others
References
K. A. Broniowska, A. R. Diers, and N. Hogg, “S-nitrosoglutathione,” Biochim. Biophys. Acta, 1830, No. 5, 3173–3181 (2013).
C. B. Smith and M. A. Marletta, “Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling,” Curr. Opin. Chem. Biol., 16, Nos. 5-6, 498–506 (2012).
S. Furuta, “Basal S-nitrosylation is the guardian of tissue homeostasis,” Trends Cancer, 3, No. 11, 744–748 (2017).
A. Martínez-Ruiz and S. Lamas, “Signalling by NOinduced protein S-nitrosylation and S-glutathionylation: convergences and divergences,” Cardiovasc. Res., 75, No. 2, 220–228 (2007).
J. W. Park, “Reaction of S-nitrosoglutathione with sulfhydryl groups in protein,” Biochem. Biophys. Res. Commun., 152, No. 2, 916–920 (1988).
M. S. Choi, “Pathophysiological role of S-nitrosylation and transnitrosylation depending on S-nitrosoglutathione levels regulated by S-nitrosoglutathione reductase,” Biomol. Ther. (Seoul), 26, No. 6, 533–538 (2018).
H. Zeng, N. Y. Spencer, and N. Hogg, “Metabolism of S-nitrosoglutathione by endothelial cells,” Am. J. Physiol. Heart Circ. Physiol., 281, No. 1, H432–H439 (2001).
I. Hornyák, E. Pankotai, L. Kiss, and Z. Lacza, “Current developments in the therapeutic potential of S-nitrosoglutathione, an endogenous NO-donor molecule,” Curr. Pharm. Biotechnol., 12, No. 9, 1368–1374 (2011).
P. Rauhala, T. Andoh, and C. C. Chiueh, “Neuroprotective properties of nitric oxide and S-nitrosoglutathione,” Toxicol. Appl. Pharmacol., 207, Suppl. 2, 91–95 (2005).
J. He, H. Kang, F. Yan, and C. Chen, “The endoplasmic reticulum-related events in S-nitrosoglutathione-induced neurotoxicity in cerebellar granule cells,” Brain Res., 1015, Nos. 1-2, 25–33 (2004).
G. Blanco and R. W. Mercer, “Isozymes of the Na-KATPase: heterogeneity in structure, diversity in function,” Am. J. Physiol., 275, No. 5, F633–F650 (1998).
E. Carafoli, “Calcium pump of the plasma membrane,” Physiol. Rev., 71, No. 1, 129–153 (1991).
M. Brini, T. Calì, D. Ottolini, and E. Carafoli, “The plasma membrane calcium pump in health and disease,” FEBS J., 280, No. 21, 5385–5397 (2013).
K. M. Chan, D. Delfert, and K. D. Junger, “A direct colorimetric assay for Ca2+-stimulated ATPase activity,” Anal. Biochem., 157, No. 2, 375–380 (1986).
A. G. Splittgerber and J. Sohl, “Nonlinearity in protein assays by the Coomassie blue dye-binding method,” Anal. Biochem., 179, No. 2, 198–201 (1989).
J. Yan, Q. Shi, Z. Chen, et al., “Skeletal muscle aldolase an overexpression in endotoxemic rats and inhibited by GSNO via potential role for S-nitrosylation in vitro,” J. Surg. Res., 170, No. 1, e57–63 (2011).
L. Nogueira, C. Figueiredo-Freitas, G. Casimiro-Lopes, et al., “Myosin is reversibly inhibited by S-nitrosylation,” Biochem. J., 424, No. 2, 221–231 (2009).
J. Sun, N. Yamaguchi, L. Xu, et al., “Regulation of the cardiac muscle ryanodine receptor by O2 tension and S-nitrosoglutathione,” Biochemistry, 47, No. 52, 13985–13990 (2008).
M. R. Kapadia, J. W. Eng, Q. Jiang, et al., “Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells,” Nitric Oxide, 20, No. 4, 279–288 (2009).
D. Giustarini, A. Milzani, G. Aldini, et al., “S-nitrosation versus S-glutathionylation of protein sulfhydryl groups by S-nitrosoglutathione,” Antioxid. Redox. Signal., 7, Nos. 7-8, 930–939 (2005).
I. Y. Petrushanko, S. Yakushev, V. A. Mitkevich, et al., “S-glutathionylation of the Na,K-ATPase catalytic α subunit is a determinant of the enzyme redox sensitivity,” J. Biol. Chem., 287, No. 38, 32195–31205 (2012).
C. C. Liu, K. Karimi Galougahi, R. M. Weisbrod, et al., “Oxidative inhibition of the vascular Na+-K+ pump via NADPH oxidase-dependent β1-subunit glutathionylation: implications for angiotensin II-induced vascular dysfunction,” Free Radic. Biol. Med., 65, 563–572 (2013).
M. Kunimoto, H. Tsubone, N. Tsujii, et al., “Toxic effects of nitrate and nitrite, chemical intermediates of inhaled nitrogen dioxide, on membrane components of red blood cells of rats.,” Appl. Pharmacol., 74, No. 1, 10–16 (1984).
I. Mangialavori, M. Ferreira-Gomes, M. F. Pignataro, et al., “Determination of the dissociation constants for Ca2+ and calmodulin from the plasma membrane Ca2+ pump by a lipid probe that senses membrane domain changes,” J. Biol. Chem., 285, No. 1, 123–130 (2010).
M. Brini, L. Coletto, N. Pierobon, et al., “A comparative functional analysis of plasma membrane Ca2+ pump isoforms in intact cells,” J. Biol. Chem., 278, No. 27, 24500–2458 (2003).
M. Forgac, “The vacuolar H+-ATPase of clathrin-coated vesicles is reversibly inhibited by S-nitrosoglutathione,” J. Biol. Chem., 274, No. 3, 1301–1305 (1999).
D. Giustarini, I. Dalle-Donne, A. Milzani, and R. Rossi, “Low molecular mass thiols, disulfides and protein mixed disulfides in rat tissues: influence of sample manipulation, oxidative stress and ageing,” Mech. Ageing Dev., 132, No. 4, 141–148 (2011).
I. Kluge, U. Gutteck-Amsler, M. Zollinger, and K. Q. Do, “S-nitrosoglutathione in rat cerebellum: identification and quantification by liquid chromatography-mass spectrometry,” J. Neurochem., 69, No. 6, 2599–607 (1997).
K. Zaman, L. A Palmer, A. Doctor, et al., “Concentrationdependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1,” Biochem. J., 380, Pt. 1, 67–74 (2004).
L. Tao, and A. M. English, “Mechanism of S-nitrosation of recombinant human brain calbindin D28K,” Biochemistry, 42, No. 11, 3326–3334 (2003).
S. R. Jaffrey, H. Erdjument-Bromage, C. D. Ferris, et al., “Protein S-nitrosylation: a physiological signal for neuronal nitric oxide,” Nat. Cell Biol., 2, 193–197 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsyvkin, V.N., Prudnikov, I.M., Smirnov, A.N. et al. Partial Inhibition of Na+/K+-ATPase and Plasma Membrane Ca2+-ATPase from the Rat Cerebral Cortex by S-Nitrosoglutathione. Neurophysiology 52, 178–185 (2020). https://doi.org/10.1007/s11062-020-09868-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11062-020-09868-z